Vanguard Group Inc Aquestive Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,242,571 shares of AQST stock, worth $7.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,242,571
Previous 1,889,053
71.65%
Holding current value
$7.49 Million
Previous $3.82 Million
262.07%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AQST
# of Institutions
105Shares Held
42.1MCall Options Held
463KPut Options Held
431K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$22.7 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$12.8 Million2.03% of portfolio
-
Franklin Resources Inc San Mateo, CA2.22MShares$5.13 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY1.55MShares$3.57 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.38MShares$3.18 Million0.01% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $123M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...